Dr Reddy's gets 8 observations from USFDA for its Duvvada facility

21 Aug 2019

US Food and Drug Administration (USFDA) has issued eight observations to Dr Reddy's Laboratories after the inspection of Formulations Manufacturing plant (Vizag SEZ Plant 1) at Duvvada, Visakhapatnam in Andhra Pradesh. The company has been issued Form 483 with 8 observations. The company will address them comprehensively within the stipulated timeline.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Related Dr. Reddys Laboratories Ltd. Links:

Dr. Reddys Lab Share Price

5187.05 103.55 (2.04%) Sep 30, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 500.50
Dr. Reddys Lab 5187.05
Lupin 1007.10
Piramal Enterprises 1251.95
Cadila Healthcare 394.90
View more..
Sensex vs Dr. Reddys Lab
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback